Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $678.46 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nestle HealthCare Nutrition Inc. | $166.03 | 7 | $0 (2021) |
| Amgen Inc. | $119.11 | 1 | $0 (2017) |
| SANOFI PASTEUR INC. | $70.80 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $70.33 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $64.73 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $44.46 | 3 | $0 (2020) |
| ABBVIE INC. | $31.17 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $24.97 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $24.88 | 1 | $0 (2024) |
| Seqirus USA Inc | $20.23 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.29 | 5 | ABBVIE INC. ($31.17) |
| 2023 | $17.75 | 1 | Phadia US Inc. ($17.75) |
| 2022 | $40.40 | 2 | SANOFI PASTEUR INC. ($24.36) |
| 2021 | $200.12 | 9 | Nestle HealthCare Nutrition Inc. ($117.88) |
| 2020 | $105.61 | 6 | Nestle HealthCare Nutrition Inc. ($48.15) |
| 2019 | $60.51 | 4 | Amarin Pharma Inc. ($19.04) |
| 2017 | $136.78 | 2 | Amgen Inc. ($119.11) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ANTIBIOTIC | ||||||
| 08/29/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Vaccines | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Allergy/Immunology | ||||||
| 09/27/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: VACCINES | ||||||
| 09/08/2022 | SANOFI PASTEUR INC. | VAXELIS (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Vaccines | ||||||
| 09/03/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: VACCINES | ||||||
| 08/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiovascular | ||||||
| 06/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/13/2021 | SANOFI PASTEUR INC. | VAXELIS (Biological), FLUZONE QUADRIVALENT, MENQUADFI | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Vaccines | ||||||
| 04/06/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/12/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/08/2020 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/10/2020 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/06/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/24/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/16/2020 | Bausch Health US, LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), PENTACEL, ADACEL | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: VACCINES | ||||||
| 09/30/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, SHINGRIX | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 42 | 78 | $716.00 | $345.03 |
| 2022 | 2 | 36 | 71 | $725.00 | $350.68 |
| 2021 | 2 | 39 | 60 | $568.00 | $318.97 |
| 2020 | 2 | 61 | 114 | $966.00 | $582.86 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 30 | 63 | $435.00 | $202.23 | 46.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 15 | $281.00 | $142.80 | 50.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 19 | $361.00 | $182.19 | 50.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 21 | 52 | $364.00 | $168.49 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 15 | 19 | $333.00 | $184.49 | 55.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 24 | 41 | $235.00 | $134.48 | 57.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 28 | 33 | $561.00 | $318.72 | 56.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 33 | 81 | $405.00 | $264.14 | 65.2% |
About Dr. Muhammad Iqbal, M.D
Dr. Muhammad Iqbal, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578515896.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Iqbal, M.D has received a total of $678.46 in payments from pharmaceutical and medical device companies, with $117.29 received in 2024. These payments were reported across 29 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($678.46).
As a Medicare-enrolled provider, Iqbal has provided services to 178 Medicare beneficiaries, totaling 323 services with total Medicare billing of $1,598. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Nephrology
- Location Pasadena, CA
- Active Since 05/16/2006
- Last Updated 08/11/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578515896
Products in Payments
- ZENPEP (Drug) $166.03
- Repatha (Biological) $119.11
- Vascepa (Drug) $64.73
- XIFAXAN (Drug) $44.46
- VAXELIS (Biological) $40.96
- BEXSERO (Biological) $38.25
- SHINGRIX (Biological) $32.08
- UBRELVY (Drug) $31.17
- NUZYRA (Drug) $24.97
- TREMFYA (Drug) $24.88
- Flucelvax (Biological) $20.23
- ImmunoCAP (Device) $17.75
- MENACTRA (Drug) $17.67
- MIGRANAL (Drug) $13.00
- FLUZONE HIGH-DOSE (Drug) $12.17
- ROTATEQ (Biological) $11.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882